| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |